Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s): 318

Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V Allen, Jr., PhD, RPh, formulation, cinacalcet, calcimimetic agent, calcium-sensing receptors, secondary hyperparathyroidism, parathyroid cancer, parathyroid disorders

Related Categories: CANCER AND AIDS, FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 318
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Methylprednisolone 4-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 340
Calcium Acetate 667-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 229
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53